These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16759158)

  • 41. Melanoma susceptibility genes and risk assessment.
    Marzuka-Alcalá A; Gabree MJ; Tsao H
    Methods Mol Biol; 2014; 1102():381-93. PubMed ID: 24258989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genotypic hypervariability of melanoma: a therapeutic challenge].
    Dalle S; Martin-Denavit T; Thomas L
    Med Sci (Paris); 2006 Feb; 22(2):178-82. PubMed ID: 16457759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
    Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic testing for melanoma predisposition: current challenges.
    Gerstenblith MR; Goldstein AM; Tucker MA; Fraser MC
    Cancer Nurs; 2007; 30(6):452-9; quiz 462-3. PubMed ID: 18025917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
    Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
    Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
    Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
    Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.
    Pellegrini C; Fargnoli MC; Suppa M; Peris K
    BMC Med Genet; 2012 Sep; 13():81. PubMed ID: 22978401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. eMelanoBase: an online locus-specific variant database for familial melanoma.
    Fung DC; Holland EA; Becker TM; Hayward NK; Bressac-de Paillerets B; Mann GJ;
    Hum Mutat; 2003 Jan; 21(1):2-7. PubMed ID: 12497626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetics of pigmentation and melanoma predisposition.
    Pho LN; Leachman SA
    G Ital Dermatol Venereol; 2010 Feb; 145(1):37-45. PubMed ID: 20197744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Normal repair of ultraviolet radiation-induced DNA damage in familial melanoma without CDKN2A or CDK4 gene mutation.
    Shannon JA; Matias C; Luxford C; Kefford RF; Mann GJ
    Melanoma Res; 1999 Apr; 9(2):133-7. PubMed ID: 10380935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT.
    Daniotti M; Ferrari A; Frigerio S; Casieri P; Miselli F; Zucca E; Collini P; Della Torre G; Manoukian S; Peissel B; Bono A; Santinami M; Parmiani G; Rivoltini L; Pilotti S; Rodolfo M
    J Invest Dermatol; 2009 Jul; 129(7):1759-68. PubMed ID: 19158841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
    de Snoo FA; Hottenga JJ; Gillanders EM; Sandkuijl LA; Jones MP; Bergman W; van der Drift C; van Leeuwen I; van Mourik L; Huurne JA; Frants RR; Willemze R; Breuning MH; Trent JM; Gruis NA
    Eur J Hum Genet; 2008 Sep; 16(9):1135-41. PubMed ID: 18398432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Germline MC1R variants and BRAF mutant melanoma.
    Hacker E; Hayward NK
    J Invest Dermatol; 2008 Oct; 128(10):2354-6. PubMed ID: 18787543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetics of familial cutaneous melanoma.
    Haluska FG; Hodi FS
    J Clin Oncol; 1998 Feb; 16(2):670-82. PubMed ID: 9469357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melanoma etiology: where are we?
    Tucker MA; Goldstein AM
    Oncogene; 2003 May; 22(20):3042-52. PubMed ID: 12789279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics of familial melanoma: 20 years after CDKN2A.
    Aoude LG; Wadt KA; Pritchard AL; Hayward NK
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):148-60. PubMed ID: 25431349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic mutations involved in melanoma: a summary of our current understanding.
    High WA; Robinson WA
    Adv Dermatol; 2007; 23():61-79. PubMed ID: 18159896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetics of melanoma predisposition.
    Lin J; Hocker TL; Singh M; Tsao H
    Br J Dermatol; 2008 Aug; 159(2):286-91. PubMed ID: 18547303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genetics of cutaneous melanoma.
    Pollock PM; Trent JM
    Clin Lab Med; 2000 Dec; 20(4):667-90. PubMed ID: 11221509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rarity of CDK4 germline mutations in familial melanoma.
    Goldstein AM; Chidambaram A; Halpern A; Holly EA; Guerry IV D; Sagebiel R; Elder DE; Tucker MA
    Melanoma Res; 2002 Feb; 12(1):51-5. PubMed ID: 11828258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.